Cargando…

Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit

AIMS/INTRODUCTION: We compared the results of testing for glutamic acid decarboxylase antibodies (GADAb) using a radioimmunoassay (RIA) and an enzyme‐linked immunosorbent assay (ELISA) in individuals with childhood‐onset type 1 diabetes mellitus. MATERIALS AND METHODS: Serum specimens were collected...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugihara, Shigetaka, Yokota, Ichiro, Mukai, Tokuo, Mochizuki, Takahiro, Nakayama, Masashi, Tachikawa, Emiko, Kawada, Yasumasa, Minamitani, Kinship, Kikuchi, Nobuyuki, Urakami, Tatsuhiko, Kawamura, Tomoyuki, Kawasaki, Eiji, Kikuchi, Toru, Amemiya, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232289/
https://www.ncbi.nlm.nih.gov/pubmed/31756289
http://dx.doi.org/10.1111/jdi.13184
_version_ 1783535353458589696
author Sugihara, Shigetaka
Yokota, Ichiro
Mukai, Tokuo
Mochizuki, Takahiro
Nakayama, Masashi
Tachikawa, Emiko
Kawada, Yasumasa
Minamitani, Kinship
Kikuchi, Nobuyuki
Urakami, Tatsuhiko
Kawamura, Tomoyuki
Kawasaki, Eiji
Kikuchi, Toru
Amemiya, Shin
author_facet Sugihara, Shigetaka
Yokota, Ichiro
Mukai, Tokuo
Mochizuki, Takahiro
Nakayama, Masashi
Tachikawa, Emiko
Kawada, Yasumasa
Minamitani, Kinship
Kikuchi, Nobuyuki
Urakami, Tatsuhiko
Kawamura, Tomoyuki
Kawasaki, Eiji
Kikuchi, Toru
Amemiya, Shin
author_sort Sugihara, Shigetaka
collection PubMed
description AIMS/INTRODUCTION: We compared the results of testing for glutamic acid decarboxylase antibodies (GADAb) using a radioimmunoassay (RIA) and an enzyme‐linked immunosorbent assay (ELISA) in individuals with childhood‐onset type 1 diabetes mellitus. MATERIALS AND METHODS: Serum specimens were collected from 1,024 Japanese children (426 boys and 598 girls) in 2013. The median age at diagnosis was 7 years (0–18 years). The blood specimens were obtained at a median age of 13 years (2–22 years). RESULTS: Among the 628 children whose serum specimens were collected within 5 years after diagnosis, the rate of GADAb positivity was 47.9% using RIA and 69.4% using ELISA. The participants were divided into four groups according to their RIA and ELISA results for GADAb as follows: group I (RIA+/ELISA+), group II (RIA+/ELISA−), group III (RIA−/ELISA+) and group IV (RIA−/ELISA−). The clinical and genetic characteristics of group I and group III were quite similar in terms of age at diagnosis, male/female ratio, relatively high positive rates for both autoantibody to protein tyrosine phosphatase IA‐2 and autoantibody to the cation efflux transporter zinc transporter 8, and human leukocyte antigen genotype. Group II contained just five patients, and was characterized by a younger age at diagnosis, low positive rates for both autoantibody to protein tyrosine phosphatase IA‐2 and autoantibody to the cation efflux transporter zinc transporter 8, and a unique human leukocyte antigen genotype. If the positive rates of either autoantibody to protein tyrosine phosphatase IA‐2 or autoantibody to the cation efflux transporter zinc transporter 8 or both were added to the GADAb results using RIA, the percentage of autoimmune type 1 diabetes increased from 47.9% to 78.5%. CONCLUSIONS: The diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes increased when GADAb results were obtained using a new ELISA method, compared with a previously utilized RIA method.
format Online
Article
Text
id pubmed-7232289
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72322892020-05-19 Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit Sugihara, Shigetaka Yokota, Ichiro Mukai, Tokuo Mochizuki, Takahiro Nakayama, Masashi Tachikawa, Emiko Kawada, Yasumasa Minamitani, Kinship Kikuchi, Nobuyuki Urakami, Tatsuhiko Kawamura, Tomoyuki Kawasaki, Eiji Kikuchi, Toru Amemiya, Shin J Diabetes Investig Articles AIMS/INTRODUCTION: We compared the results of testing for glutamic acid decarboxylase antibodies (GADAb) using a radioimmunoassay (RIA) and an enzyme‐linked immunosorbent assay (ELISA) in individuals with childhood‐onset type 1 diabetes mellitus. MATERIALS AND METHODS: Serum specimens were collected from 1,024 Japanese children (426 boys and 598 girls) in 2013. The median age at diagnosis was 7 years (0–18 years). The blood specimens were obtained at a median age of 13 years (2–22 years). RESULTS: Among the 628 children whose serum specimens were collected within 5 years after diagnosis, the rate of GADAb positivity was 47.9% using RIA and 69.4% using ELISA. The participants were divided into four groups according to their RIA and ELISA results for GADAb as follows: group I (RIA+/ELISA+), group II (RIA+/ELISA−), group III (RIA−/ELISA+) and group IV (RIA−/ELISA−). The clinical and genetic characteristics of group I and group III were quite similar in terms of age at diagnosis, male/female ratio, relatively high positive rates for both autoantibody to protein tyrosine phosphatase IA‐2 and autoantibody to the cation efflux transporter zinc transporter 8, and human leukocyte antigen genotype. Group II contained just five patients, and was characterized by a younger age at diagnosis, low positive rates for both autoantibody to protein tyrosine phosphatase IA‐2 and autoantibody to the cation efflux transporter zinc transporter 8, and a unique human leukocyte antigen genotype. If the positive rates of either autoantibody to protein tyrosine phosphatase IA‐2 or autoantibody to the cation efflux transporter zinc transporter 8 or both were added to the GADAb results using RIA, the percentage of autoimmune type 1 diabetes increased from 47.9% to 78.5%. CONCLUSIONS: The diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes increased when GADAb results were obtained using a new ELISA method, compared with a previously utilized RIA method. John Wiley and Sons Inc. 2019-12-24 2020-05 /pmc/articles/PMC7232289/ /pubmed/31756289 http://dx.doi.org/10.1111/jdi.13184 Text en © 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Articles
Sugihara, Shigetaka
Yokota, Ichiro
Mukai, Tokuo
Mochizuki, Takahiro
Nakayama, Masashi
Tachikawa, Emiko
Kawada, Yasumasa
Minamitani, Kinship
Kikuchi, Nobuyuki
Urakami, Tatsuhiko
Kawamura, Tomoyuki
Kawasaki, Eiji
Kikuchi, Toru
Amemiya, Shin
Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit
title Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit
title_full Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit
title_fullStr Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit
title_full_unstemmed Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit
title_short Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit
title_sort increased diagnosis of autoimmune childhood‐onset japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232289/
https://www.ncbi.nlm.nih.gov/pubmed/31756289
http://dx.doi.org/10.1111/jdi.13184
work_keys_str_mv AT sugiharashigetaka increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT yokotaichiro increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT mukaitokuo increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT mochizukitakahiro increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT nakayamamasashi increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT tachikawaemiko increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT kawadayasumasa increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT minamitanikinship increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT kikuchinobuyuki increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT urakamitatsuhiko increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT kawamuratomoyuki increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT kawasakieiji increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT kikuchitoru increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT amemiyashin increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit
AT increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit